Evaluating side effects of nanoparticle-mediated siRNA delivery to mesenchymal stem cells using next generation sequencing and enrichment analysis.

Journal Information

Full Title: Bioeng Transl Med

Abbreviation: Bioeng Transl Med

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Engineering, Biomedical

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Evidence found in paper:

"raw reads were generated from an illumina hiseq2500 sequencer and all sequencing data discussed in this publication have been deposited in ncbi's gene expression omnibus (geo) 64 .; all files are accessible through geo series accession number gse87497 ( https://www ncbi nlm nih gov/geo/query/acc cgi? xlsx" table s6"

Code Sharing
Evidence found in paper:

"Conflict of interests The authors have no conflicts of interest related to this work."

Evidence found in paper:

"Funding Information Funding for this work came from the National Science Foundation (DMR‐1206219), the New York State Stem cell Science program (NYSTEM IDEA‐N11G‐035), the National Institutes of Health (R01 AR064200, AR056696 and P30 ES001247), and the University of Rochester's Health Sciences Center for Computational Innovation (HSCCI)."

Protocol Registration
Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025